FDA Inspection 861164 — Alexey Blokhin
The FDA completed an inspection of Alexey Blokhin on December 20, 2013 in Moscow. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 20, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Moscow (Russia)
Additional Details
Clinical Investigator (CI)